Central Trust CO Organon & Co. Transaction History

Central Trust CO

$4.19 Billion
Q3 2024

A detailed history of Central Trust CO transactions in Organon & Co. stock. As of the latest transaction made, Central Trust CO holds 1,523 shares of OGN stock, worth $22,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,523

Previous 1,848 17.59%

Holding current value

$22,890

Previous $38,000 23.68%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$18.65 - $23.03 $6,061 - $7,484	-325 Reduced 17.59%	1,523 $29,000
Q2 2024 Aug 05, 2024	BUY	$17.45 - $21.96 $1,989 - $2,503	114 Added 6.57%	1,848 $38,000
Q1 2024 Apr 24, 2024	SELL	$13.78 - $18.8 $1,267 - $1,729	-92 Reduced 5.04%	1,734 $32,000
Q4 2023 Jan 24, 2024	BUY	$10.95 - $17.32 $843 - $1,333	77 Added 4.4%	1,826 $26,000
Q3 2023 Oct 26, 2023	SELL	$16.59 - $23.77 $2,040 - $2,923	-123 Reduced 6.57%	1,749 $30,000
Q2 2023 Jul 26, 2023	SELL	$19.27 - $24.63 $9,635 - $12,315	-500 Reduced 21.08%	1,872 $38,000
Q1 2023 Apr 19, 2023	SELL	$21.42 - $32.08 $23,133 - $34,646	-1,080 Reduced 31.29%	2,372 $55,000
Q4 2022 Jan 26, 2023	SELL	$23.31 - $28.61 $119,417 - $146,569	-5,123 Reduced 59.74%	3,452 $0
Q3 2022 Nov 17, 2022	SELL	$23.4 - $34.25 $3,673 - $5,377	-157 Reduced 1.8%	8,575 $201,000
Q2 2022 Aug 09, 2022	SELL	$31.66 - $38.9 $28,145 - $34,582	-889 Reduced 9.24%	8,732 $295,000
Q1 2022 May 03, 2022	BUY	$30.45 - $39.36 $13,702 - $17,712	450 Added 4.91%	9,621 $336,000
Q4 2021 Feb 08, 2022	BUY	$28.67 - $37.13 $20,814 - $26,956	726 Added 8.6%	9,171 $279,000
Q3 2021 Oct 19, 2021	SELL	$28.63 - $35.64 $64,245 - $79,976	-2,244 Reduced 20.99%	8,445 $276,000
Q2 2021 Jul 23, 2021	BUY	$28.45 - $38.0 $304,102 - $406,182	10,689 New	10,689 $323,000

Others Institutions Holding OGN

# of Institutions

790

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.82B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account